These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33758121)

  • 1. Clinical Implications and Debates on the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches Trial.
    Saito Y; Nishi T; Saito K; Kitahara H; Kawase Y; Matsuo H; Kobayashi Y
    Cardiol Rev; 2022 Sep-Oct 01; 30(5):234-240. PubMed ID: 33758121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation).
    Fearon WF; Nishi T; De Bruyne B; Boothroyd DB; Barbato E; Tonino P; Jüni P; Pijls NHJ; Hlatky MA;
    Circulation; 2018 Jan; 137(5):480-487. PubMed ID: 29097450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA.
    Phillips LM; Hachamovitch R; Berman DS; Iskandrian AE; Min JK; Picard MH; Kwong RY; Friedrich MG; Scherrer-Crosbie M; Hayes SW; Sharir T; Gosselin G; Mazzanti M; Senior R; Beanlands R; Smanio P; Goyal A; Al-Mallah M; Reynolds H; Stone GW; Maron DJ; Shaw LJ
    J Nucl Cardiol; 2013 Dec; 20(6):969-75. PubMed ID: 23963599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).
    Lønborg J; Engstrøm T; Kelbæk H; Helqvist S; Kløvgaard L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L; Høfsten DE;
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous coronary intervention from COURAGE to ISCHEMIA and beyond.
    Weintraub WS; Mancini GBJ; Boden WE
    Int J Cardiol; 2023 Feb; 373():39-43. PubMed ID: 36427605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of trials on mortality after percutaneous coronary intervention compared with medical therapy in patients with stable coronary heart disease and objective evidence of myocardial ischemia.
    Gada H; Kirtane AJ; Kereiakes DJ; Bangalore S; Moses JW; Généreux P; Mehran R; Dangas GD; Leon MB; Stone GW
    Am J Cardiol; 2015 May; 115(9):1194-9. PubMed ID: 25759103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.
    ; Maron DJ; Hochman JS; O'Brien SM; Reynolds HR; Boden WE; Stone GW; Bangalore S; Spertus JA; Mark DB; Alexander KP; Shaw L; Berger JS; Ferguson TB; Williams DO; Harrington RA; Rosenberg Y
    Am Heart J; 2018 Jul; 201():124-135. PubMed ID: 29778671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Outcomes of Invasive or Conservative Management of Chronic Coronary Disease in Four Randomized Controlled Trials.
    Mavromatis K; Boden WE; Maron DJ; Mancini GBJ; Weintraub WS; Gosselin G; Berman DS; Shaw LJ; Spertus JA; Hochman JS
    Am J Cardiol; 2022 Dec; 185():18-28. PubMed ID: 36257844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in geographic variation in the use of percutaneous coronary intervention for stable ischemic heart disease after publication of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.
    Mohan AV; Fazel R; Huang PH; Shen YC; Howard D
    Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):125-30. PubMed ID: 24347661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.
    Stone GW; Hochman JS; Williams DO; Boden WE; Ferguson TB; Harrington RA; Maron DJ
    J Am Coll Cardiol; 2016 Jan; 67(1):81-99. PubMed ID: 26616030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial.
    Hochman JS; Reynolds HR; Bangalore S; O'Brien SM; Alexander KP; Senior R; Boden WE; Stone GW; Goodman SG; Lopes RD; Lopez-Sendon J; White HD; Maggioni AP; Shaw LJ; Min JK; Picard MH; Berman DS; Chaitman BR; Mark DB; Spertus JA; Cyr DD; Bhargava B; Ruzyllo W; Wander GS; Chernyavskiy AM; Rosenberg YD; Maron DJ;
    JAMA Cardiol; 2019 Mar; 4(3):273-286. PubMed ID: 30810700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiology over Angiography to Determine Lesion Severity: the FAME Trials.
    Parikh RV; Fearon WF
    Interv Cardiol Clin; 2020 Oct; 9(4):409-418. PubMed ID: 32921365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The elusive role of myocardial perfusion imaging in stable ischemic heart disease: Is ISCHEMIA the answer?
    Xie JX; Winchester DE; Phillips LM; Hachamovitch R; Berman DS; Blankstein R; Di Carli MF; Miller TD; Al-Mallah MH; Shaw LJ
    J Nucl Cardiol; 2017 Oct; 24(5):1610-1618. PubMed ID: 28752313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial Ischemia in the Management of Chronic Coronary Artery Disease: Past and Present.
    Gibbons RJ
    Circ Cardiovasc Imaging; 2021 Jan; 14(1):e011615. PubMed ID: 33455408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of ischemia and scar on therapeutic benefit of myocardial revascularization.
    Hachamovitch R
    Herz; 2013 Jun; 38(4):344-9. PubMed ID: 23625299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous coronary intervention for the management of stable ischemic heart disease.
    Liu S; Tsang M; Abdel-Qadir H; Yanagawa B; Bagai A
    Curr Opin Cardiol; 2019 Sep; 34(5):557-563. PubMed ID: 31246588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revascularization versus medical therapy in patients aged 80 and older with stable ischemic heart disease.
    Phan DQ; Zadegan R; Lee MS
    J Am Geriatr Soc; 2021 Dec; 69(12):3457-3467. PubMed ID: 34363216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Percutaneous Coronary Intervention on Survival in Patients with Stable Ischemic Heart Disease.
    Ujueta F; Weiss EN; Shah B; Sedlis SP
    Curr Cardiol Rep; 2017 Feb; 19(2):17. PubMed ID: 28213668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appropriate therapy for patients with stable ischemic heart disease: a review of literature and the implication of the International Study of Comparative Effectiveness with Medical and Invasive Approaches trial.
    Guo MH; Nantsios A; Ruel M
    Curr Opin Cardiol; 2020 Nov; 35(6):658-663. PubMed ID: 32941193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia.
    Mancini GBJ; Hartigan PM; Shaw LJ; Berman DS; Hayes SW; Bates ER; Maron DJ; Teo K; Sedlis SP; Chaitman BR; Weintraub WS; Spertus JA; Kostuk WJ; Dada M; Booth DC; Boden WE
    JACC Cardiovasc Interv; 2014 Feb; 7(2):195-201. PubMed ID: 24440015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.